| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 08/23/2007 | WO2007095124A2 Benzazole derivatives, compositions, and methods of use as aurora kinase inhibitors |
| 08/23/2007 | WO2007094513A2 Cyclic amine compound and use thereof for the prophylaxis or treatment of hypertension |
| 08/23/2007 | WO2007094015A1 An improved process for the preparation of candesartan cilexetil |
| 08/23/2007 | WO2007093542A1 Pyridine-2-carboxamide derivatives |
| 08/23/2007 | WO2007093363A1 Novel azacycly-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments |
| 08/23/2007 | WO2007071396A3 Pyrazinoylguanidine compounds useful in the treatment of inflammatory or allergic conditions |
| 08/23/2007 | WO2007061741A3 Modulators of the h3 receptor useful for the treatment of disorders related thereto |
| 08/23/2007 | WO2007059257A3 N4-phenyl-quinaz0line-4 -amine derivatives and related compounds as erbb type i receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases |
| 08/23/2007 | US20070197794 Method for preparing pyrrolidine oximes |
| 08/23/2007 | US20070197792 Process for the preparation of the insecticide imidacloprid |
| 08/23/2007 | US20070197783 Compositions and methods of treating cell proliferation disorders |
| 08/23/2007 | US20070197782 N4-[2,2-Dimethyl-3-oxo-benzo[1,4]thiazin-6-yl]-5-fluoro-N2-(3-hydroxy-4,5-dimethoxyphenyl)-2,4-pyrimidinediamine;5-Fluoro-N2-(3-hydroxy-4,5-dimethoxyphenyl)-N4-[3-oxo-benzo[1,4]thiazin-6-yl]-2,4-pyrimidinediamine; autoimmune diseases |
| 08/23/2007 | US20070197625 Azabicyclic compounds, a process for their preparation and pharmaceutical compositions containing them. |
| 08/23/2007 | US20070197619 Ion Channel Modulators |
| 08/23/2007 | US20070197617 2-[(S)-2-((S)-2,5-dioxo-4-phenyl-imidazolidin-1-yl)-4-methyl-pentanoylamino]-thiazole-4-carboxylic acid methyl ester; mitogen activated protein/extracellular signal regulated kinase kinase inhibitor; anticarcinogenic agent, cognition activator, nervous and autoimmune system disorders |
| 08/23/2007 | US20070197580 To treat irritable bowel syndrome; side effect reduction, improved pharmacodynamics and safety, more potent and selective; 2-imidazomethyl- pyrido(4,3-b)indol-1-one or -carbazol-1-one derivatives containing an ester group |
| 08/23/2007 | US20070197566 Novel pyrazolylquinazolinones as potassium channel openers |
| 08/23/2007 | US20070197561 Inhibitors of nucleoside metabolism |
| 08/23/2007 | US20070197553 4-Aryl-pyridine-2-carboxyamide derivatives |
| 08/23/2007 | US20070197549 Tetrazole compounds and their use as metabotropic glutamate receptor antagonists |
| 08/23/2007 | US20070197547 4-(1-piperazinyl)-2(1H)-quinolone and 4-(1-piperazinyl)quinoline derivatives, e.g., 4-(1-piperazinyl)-1-methyl-3-nitro-2(1H)-quinolone |
| 08/23/2007 | US20070197545 Crystalline Polymorphs Of Methanesulfonic Acid Addition Salts Of Imatinib |
| 08/23/2007 | US20070197542 hydroxy{(1S)-4-pyrimidin-2-yl-1-[({4-[5-(2,2,2-trifluoroethoxy)pyrimidin-2-yl]piperazin-1-yl}sulfonyl)methyl]butyl}formamide; collagenase 3 inhibitor; tissue remodelling such as embryonic development, bone formation and uterine remodelling during menstruation |
| 08/23/2007 | US20070197536 Pyridazin-3(2)-one derivatives and their use as pde4 inhibitors |
| 08/23/2007 | US20070197533 Antibacterial 3,5-diaminopiperidine-substituted aromatic and heteroaromatic compounds |
| 08/23/2007 | US20070197532 Glucokinase activators |
| 08/23/2007 | US20070197530 Cycloalkylcarbonyl-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-ones: 1'-{[1-(4-Chlorophenyl)cyclo-pentyl]carbonyl}-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-one; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; antidiabetic agents |
| 08/23/2007 | US20070197526 Pyrazoles for the treatment of obesity and other CNS disorders |
| 08/23/2007 | US20070197524 Fluorenes and carbazoles as ligands of the EP2 receptor |
| 08/23/2007 | US20070197513 calcium channel modulator; [[1-(4-{2-[1-(4-Chloro-phenyl)-2-(2-methoxy-phenyl)-1H-imidazol-4-yl]-ethyl}-(4-fluoro-phenyl)-methyl-amine; analgesic, antidiabetic agent; angina, hypertension, myocardial ischemia, arrhythmia, diabetes, urinary incontinence, stroke, pain, brain injury, or neuronal disorders |
| 08/23/2007 | US20070197509 Compositions and methods for modulating gated ion channels |
| 08/23/2007 | US20070197504 tert-butyl 4-{[3-({[(6-methyl-3-pyridyl)amino]carbonylamino}methyl)phenyl]methyl}-piperazinecarboxylate; selectively modulates the cardiac sarcomere, for example by potentiating cardiac myosin, and may be useful in the treatment of systolic heart failure including congestive heart failure |
| 08/23/2007 | US20070197502 AMINO SUBSTITUTED DIARYL[a,d]CYCLOHEPTENE ANALOGS AS MUSCARINIC AGONISTS AND METHODS OF TREATMENT OF NEUROPSYCHIATRIC DISORDERS |
| 08/23/2007 | US20070197497 Compounds, compositions and methods |
| 08/23/2007 | US20070197492 Modulation of Pathogenicity |
| 08/23/2007 | US20070196271 N-(2-[4-(2-methoxyphenyl)piperazinyl]ethyl)-N-(2-pyridyl)-N-(4-18F-fluoro-methylcyclohexane)carboxamide, used for treating panic, bipolar or seizure disorders, and as a quantitative tool for measuring serotonin concentration in the brain |
| 08/23/2007 | US20070194698 Charge transport compositions and electronic devices made with such compositions |
| 08/23/2007 | CA2640582A1 Pyridine-2-, pyrimidine-2-carboxamide derivatives |
| 08/23/2007 | CA2638787A1 Cyclic amine compound and use thereof for the prophylaxis or treatment of hypertension |
| 08/23/2007 | CA2636605A1 Novel azacycly-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments |
| 08/23/2007 | CA2618628A1 Triazole compounds that modulate hsp90 activity |
| 08/22/2007 | EP1820801A1 Organic compound, charge-transporting material, and organic electroluminescent element |
| 08/22/2007 | EP1820799A1 2,3,4,5-tetrahydro-1h-1,5-benzodiazepine derivative and medicinal composition |
| 08/22/2007 | EP1820798A1 7-membered ring compound, process for producing the same, and medicinal use thereof |
| 08/22/2007 | EP1820503A2 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| 08/22/2007 | EP1819698A1 1-[(6,7-substituted alkoxyquinoxalinyl)aminocarbonyl]-4-(hetero)arylpiperazine derivatives |
| 08/22/2007 | EP1819697A1 3-(indolyl)-4-arylmaleimide derivatives and their use as angiogenesis inhibitors |
| 08/22/2007 | EP1819680A1 Bengamides with a substituted caprolactame cycle, method for the preparation thereof, compositions containing them and use thereof |
| 08/22/2007 | EP1819341A2 Il-12 modulatory compounds |
| 08/22/2007 | EP1578755B1 Phosphonooxy quinazoline derivatives and their pharmaceutical use |
| 08/22/2007 | EP1572670B1 5-substituted-pyrazine or -pyridine glucokinase activators |
| 08/22/2007 | EP1448523B1 Heterocyclic compounds and methods of use |
| 08/22/2007 | EP1399433B1 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 08/22/2007 | CN101023078A 5-heterocyclyl pyrimidines |
| 08/22/2007 | CN101023074A Inhibitors of the interaction between MDM2 and P53 |
| 08/22/2007 | CN101023073A Heteroaroyl-substituted serine amides utilized as herbicides |
| 08/22/2007 | CN101023071A New heterocyclic amides |
| 08/22/2007 | CN101023064A Enantiomerically pure aminoheteroaryl compounds as protein kinase inhibitors |
| 08/22/2007 | CN101023063A Azine-carboxamides as anti-cancer agent |
| 08/22/2007 | CN101022728A Imidazole compounds |
| 08/21/2007 | US7259179 Kinase inhibitors |
| 08/21/2007 | US7259163 Viricides against herpes virus |
| 08/21/2007 | US7259162 Benzazole derivatives and their use as JNK modulators |
| 08/21/2007 | US7259161 For therapy of immune response, an autoimmune disease, a neurodegenerative, or a solid or hematologic malignancy |
| 08/21/2007 | US7259158 Naphthaline derivatives as H3 inverse agonists |
| 08/21/2007 | US7259155 Phosphonic diester derivatives |
| 08/21/2007 | CA2315827C Substituted pyridine and pyridazine compounds and their pharmaceutical use |
| 08/16/2007 | WO2007092558A2 Sulfonamide derivatives to treat infection with hepatitis c virus |
| 08/16/2007 | WO2007092000A1 Inhibitors of hcv replication |
| 08/16/2007 | WO2007091703A1 N-hydroxyacrylamide compounds |
| 08/16/2007 | WO2007091683A1 Bissquarylium compound |
| 08/16/2007 | WO2007091570A1 Binding inhibitor of sphingosine-1-phosphate |
| 08/16/2007 | WO2007091176A1 Pyridinone pyrazole urea and pyrimidinone pyrazole urea derivatives |
| 08/16/2007 | WO2007091046A1 Chemical compounds |
| 08/16/2007 | WO2007090752A1 Anthranilamide/2-amino-heteroarene carboxamide derivatives |
| 08/16/2007 | WO2007090343A1 LABEL-FREE OPTICAL SENSING AND CHARACTERIZATION OF BIOMOLECULES BY d8 OR d10 METAL COMPLEXES |
| 08/16/2007 | WO2007076460A3 Substituted thiazole ureas useful as inhibitors of protein kinases |
| 08/16/2007 | WO2007070826B1 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors |
| 08/16/2007 | WO2007065261B1 Plasminogen activator inhibitor-1 inhibitors |
| 08/16/2007 | US20070191604 Novel compounds that are ERK inhibitors |
| 08/16/2007 | US20070191516 Process for the synthesis of amine ethers |
| 08/16/2007 | US20070191458 Preparing an anhydrous crystal of a malic acid salt of N-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide by reacting the acid and amine in a solvent and crystallizing under various process conditions |
| 08/16/2007 | US20070191445 heat shock protein 90 inhibitors; antiproliferative agents; angiogenesis inhibitors |
| 08/16/2007 | US20070191444 Benzimidazolyl derivatives |
| 08/16/2007 | US20070191433 Dietetics; antidiabetic agents; sexual disorders |
| 08/16/2007 | US20070191431 2-Amino-5-piperidinylimidazolone compounds and use thereof for beta-secretase modulation |
| 08/16/2007 | US20070191405 Bi-aryl meta-pyrimidine inhibitors of kinases |
| 08/16/2007 | US20070191403 e.g. 3-[{hydroxycarbonylpropyl-amino}-2-phenylethyl]-5-(2-fluoro-3-methoxyphenyl)-1-[2-fluoro-6-(trifluoromethyl)benzyl]-6-methylpyrimidine-2,4(1H,3H)-dione; sex-hormone related diseases; anticarcinogenic agent; endometriosis, uterine fibroids, polycystic ovarian disease |
| 08/16/2007 | US20070191401 Transplant rejection, autoimmune disease, autoimmune disease |
| 08/16/2007 | US20070191391 Urotensin II receptor antagonists |
| 08/16/2007 | US20070191389 substituted with five-membered heterocyclics such as isopropyl 4-[1-(2-fluoropyridin-3-yl)-5-methyl-1H-[1,2,3]triazol-4-yl]-1,2,3,6-tetrahydropyridine-1-carboxylate, having glutamate receptor antagonistic activity used in the treatment of convulsions, pain, infarction, ischemia or psychological disorders |
| 08/16/2007 | US20070191387 Substituted dihydroquinazolines |
| 08/16/2007 | US20070191383 Mtp inhibiting aryl piperydines or piperazines substituted with 5-membered heterocycles |
| 08/16/2007 | US20070191372 Dna-targeted benzotriazine 1,4-dioxides and their use in cancer therapy |
| 08/16/2007 | US20070191370 Multicyclic amino acid derivatives and methods of their use |
| 08/16/2007 | US20070191363 Heteroalkyl-substituted biphenyl-4-carboxylic acid arylamide analogues |
| 08/16/2007 | US20070191362 such as (2E)-2-[1-(2,4-difluoro-phenyl)-6-(3-fluoro-benzyl)-1,4,5,6-tetrahydro-cyclopentapyrazol-3-yl]-ethenesulfonic acid [(1S)-1-phenyl-ethyl]-amide, used for treating diabetes, vision defects, pain, drug abuse, gastrointestinal and respiratory system isorders, as muscle relaxants and neuroprotectants |
| 08/16/2007 | US20070191358 Novel piperidine derivative for the treatment of depression |
| 08/16/2007 | US20070191347 Substituted sulfonamides and ureas useful for inhibiting kinase activity |
| 08/16/2007 | US20070191344 Pharmaceutically active 4,6-disubstituted aminopyrimidine derivatives as modulators of protein kinases |